99 related articles for article (PubMed ID: 16762960)
1. Impact of iron sucrose therapy on leucocyte surface molecules and reactive oxygen species in haemodialysis patients.
Guz G; Glorieux GL; De Smet R; Waterloos MA; Vanholder RC; Dhondt AW
Nephrol Dial Transplant; 2006 Oct; 21(10):2834-40. PubMed ID: 16762960
[TBL] [Abstract][Full Text] [Related]
2. Effects of intravenous iron on mononuclear cells during the haemodialysis session.
Martin-Malo A; Merino A; Carracedo J; Alvarez-Lara MA; Ojeda R; Soriano S; Crespo R; Ramirez R; Aljama P
Nephrol Dial Transplant; 2012 Jun; 27(6):2465-71. PubMed ID: 22207322
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte adhesion molecules and reactive oxygen species in preeclampsia.
Holthe MR; Staff AC; Berge LN; Lyberg T
Obstet Gynecol; 2004 May; 103(5 Pt 1):913-22. PubMed ID: 15121565
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of reactive oxygen species production and cell surface markers expression due to haemodialysis.
Cristol JP; Canaud B; Rabesandratana H; Gaillard I; Serre A; Mion C
Nephrol Dial Transplant; 1994; 9(4):389-94. PubMed ID: 8084452
[TBL] [Abstract][Full Text] [Related]
5. Effect of an extract of the mushroom Agaricus blazei Murill on expression of adhesion molecules and production of reactive oxygen species in monocytes and granulocytes in human whole blood ex vivo.
Bernardshaw S; Lyberg T; Hetland G; Johnson E
APMIS; 2007 Jun; 115(6):719-25. PubMed ID: 17550380
[TBL] [Abstract][Full Text] [Related]
6. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
[TBL] [Abstract][Full Text] [Related]
7. Oxidative status--age- and circadian variations?--a study in leukocytes/plasma.
Stritesky Larssen K; Lyberg T
Neuro Endocrinol Lett; 2006 Aug; 27(4):445-52. PubMed ID: 16891997
[TBL] [Abstract][Full Text] [Related]
8. Acute and subacute effects of EV iron sucrose on endothelial functions in hemodialysis patients.
Ozkurt S; Ozenc F; Degirmenci NA; Temiz G; Musmul A; Sahin G; Yalcin AU
Ren Fail; 2012; 34(1):1-6. PubMed ID: 22017464
[TBL] [Abstract][Full Text] [Related]
9. Effect of intravenous iron supplementation on hepatic cytochrome P450 3A4 activity in hemodialysis patients: a prospective, open-label study.
Pai AB; Norenberg J; Boyd A; Raj D; Chan LN
Clin Ther; 2007 Dec; 29(12):2699-705. PubMed ID: 18201586
[TBL] [Abstract][Full Text] [Related]
10. Intravenous iron-gluconate during haemodialysis modifies plasma beta2-microglobulin properties and levels.
Michelis R; Sela S; Kristal B
Nephrol Dial Transplant; 2005 Sep; 20(9):1963-9. PubMed ID: 15956071
[TBL] [Abstract][Full Text] [Related]
11. Dinucleoside polyphosphates: newly detected uraemic compounds with an impact on leucocyte oxidative burst.
Schepers E; Glorieux G; Jankowski V; Dhondt A; Jankowski J; Vanholder R
Nephrol Dial Transplant; 2010 Aug; 25(8):2636-44. PubMed ID: 20190246
[TBL] [Abstract][Full Text] [Related]
12. Effect of intravenous iron sucrose on oxidative stress in peritoneal dialysis patients.
Saglam F; Cavdar C; Uysal S; Cavdar Z; Camsari T
Ren Fail; 2007; 29(7):849-54. PubMed ID: 17994454
[TBL] [Abstract][Full Text] [Related]
13. Intravenous iron sucrose changes the intraperitoneal homeostasis.
Breborowicz A; Połubinska A; Kupczyk M; Wanic-Kossowka M; Oreopoulos DG
Blood Purif; 2009; 28(1):53-8. PubMed ID: 19325240
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of oral and intravenous iron therapy in haemodialysis patients.
Jenq CC; Tian YC; Wu HH; Hsu PY; Huang JY; Chen YC; Fang JT; Yang CW
Int J Clin Pract; 2008 Mar; 62(3):416-22. PubMed ID: 17511797
[TBL] [Abstract][Full Text] [Related]
15. Expression of leukocyte adhesion molecules CD11b, L-selectin and CD45 during hemodialysis.
Xu X; Yu Z; Qian J; Shi X; Chen S
Chin Med J (Engl); 1999 Dec; 112(12):1073-6. PubMed ID: 11721441
[TBL] [Abstract][Full Text] [Related]
16. Citrate anticoagulation does not correct cuprophane bioincompatibility as evaluated by the expression of leukocyte surface molecules.
Dhondt A; Vanholder R; Waterloos MA; Glorieux G; De Smet R; Lameire N
Nephrol Dial Transplant; 1998 Jul; 13(7):1752-8. PubMed ID: 9681723
[TBL] [Abstract][Full Text] [Related]
17. LeuCAM and reactive oxygen species during long-term exercise combined with sleep and energy deficiency.
Nielsen HG; Opstad PK; Lyberg T
Med Sci Sports Exerc; 2007 Feb; 39(2):275-82. PubMed ID: 17277591
[TBL] [Abstract][Full Text] [Related]
18. Increased whole blood chemiluminescence in patients with chronic renal failure independent of hemodialysis treatment.
Rysz J; Potargowicz E; Banach M; Luczyńska M; Stolarek R; Białasiewicz P; Kasielski M; Ciałkowska-Rysz A; Nowak D
Arch Immunol Ther Exp (Warsz); 2006; 54(5):347-55. PubMed ID: 17031465
[TBL] [Abstract][Full Text] [Related]
19. Bacterial DNA and endothelial damage in haemodialysis patients.
Merino A; Nogueras S; García-Maceira T; Rodríguez M; Martin-Malo A; Ramirez R; Carracedo J; Aljama P
Nephrol Dial Transplant; 2008 Nov; 23(11):3635-42. PubMed ID: 18511607
[TBL] [Abstract][Full Text] [Related]
20. Influence of polysulfone and hemophan hemodialysis membranes on phagocytes.
Kubala L; Cíz M; Soska V; Cerný J; Lojek A
Gen Physiol Biophys; 2002 Dec; 21(4):367-80. PubMed ID: 12693710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
